Neurogene Inc. Quarterly Return On Equity in % from Q3 2014 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Neurogene Inc. quarterly/annual Return On Equity history and growth rate from Q3 2014 to Q2 2024.
  • Neurogene Inc. Return On Equity for the quarter ending June 30, 2024 was -17.9 %, a 134% decline year-over-year.
  • Neurogene Inc. annual Return On Equity for 2023 was 222 %.
  • Neurogene Inc. annual Return On Equity for 2022 was -107 %, a 79.9% decline from 2021.
  • Neurogene Inc. annual Return On Equity for 2021 was -59.4 %, a 193% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -17.9 -70.6 -134% Apr 1, 2024 Jun 30, 2024
Q1 2024 -29.9 -287 -112% Jan 1, 2024 Mar 31, 2024
Q4 2023 22.9 +130 Dec 19, 2023 Dec 31, 2023
Q3 2023 40 +131 Jul 1, 2023 Sep 30, 2023
Q2 2023 52.7 +132 Apr 1, 2023 Jun 30, 2023
Q1 2023 257 +325 Jan 1, 2023 Mar 31, 2023
Q4 2022 -107 -47.4 -79.9% Oct 1, 2022 Dec 31, 2022
Q3 2022 -91 -57.4 -171% Jul 1, 2022 Sep 30, 2022
Q2 2022 -79.6 -55.2 -226% Apr 1, 2022 Jun 30, 2022
Q1 2022 -67.9 -45.2 -200% Jan 1, 2022 Mar 31, 2022
Q4 2021 -59.4 -39.1 -193% Oct 1, 2021 Dec 31, 2021
Q3 2021 -33.6 -14.7 -77.7% Jul 1, 2021 Sep 30, 2021
Q2 2021 -24.4 +47.8 +66.2% Apr 1, 2021 Jun 30, 2021
Q1 2021 -22.7 +50 +68.8% Jan 1, 2021 Mar 31, 2021
Q4 2020 -20.3 +58.6 +74.3% Oct 1, 2020 Dec 31, 2020
Q3 2020 -18.9 +74.6 +79.8% Jul 1, 2020 Sep 30, 2020
Q2 2020 -72.2 -42.1 Apr 1, 2020 Jun 30, 2020
Q1 2020 -72.6 -48 -195% Jan 1, 2020 Mar 31, 2020
Q4 2019 -78.8 -40.1 -103% Oct 1, 2019 Dec 31, 2019
Q3 2019 -93.5 -44.7 -91.5% Jul 1, 2019 Sep 30, 2019
Q2 2019 -30.1* +10.8 Apr 1, 2019 Jun 30, 2019
Q1 2019 -24.6 +28.8 +53.9% Jan 1, 2019 Mar 31, 2019
Q4 2018 -38.8 +3.53 +8.35% Oct 1, 2018 Dec 31, 2018
Q3 2018 -48.8 -14.1 -40.6% Jul 1, 2018 Sep 30, 2018
Q2 2018 -40.9 -11.3 -38.4% Apr 1, 2018 Jun 30, 2018
Q1 2018 -53.4 -24.2 -82.8% Jan 1, 2018 Mar 31, 2018
Q4 2017 -42.3 -12.4 -41.3% Oct 1, 2017 Dec 31, 2017
Q3 2017 -34.7 -7.29 -26.6% Jul 1, 2017 Sep 30, 2017
Q2 2017 -29.5 -2.38 -8.76% Apr 1, 2017 Jun 30, 2017
Q1 2017 -29.2 -3.91 -15.5% Jan 1, 2017 Mar 31, 2017
Q4 2016 -29.9 +1.48 +4.71% Oct 1, 2016 Dec 31, 2016
Q3 2016 -27.4 +19.7 +41.8% Jul 1, 2016 Sep 30, 2016
Q2 2016 -27.2 +47.9 +63.8% Apr 1, 2016 Jun 30, 2016
Q1 2016 -25.3 +40.2 +61.4% Jan 1, 2016 Mar 31, 2016
Q4 2015 -31.4 +20.5 +39.5% Oct 1, 2015 Dec 31, 2015
Q3 2015 -47.2 +46.3 +49.5% Jul 1, 2015 Sep 30, 2015
Q2 2015 -75.1 Apr 1, 2015 Jun 30, 2015
Q1 2015 -65.4 Jan 1, 2015 Mar 31, 2015
Q4 2014 -51.9 Oct 1, 2014 Dec 31, 2014
Q3 2014 -93.4 Jul 1, 2014 Sep 30, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.